Medical News

RSS

CLARIFY registry designed to increase knowledge and understanding of CAD was launched in 40 countries

CLARIFY, the largest international registry to ever be carried out in stable coronary artery disease (CAD) patients was launched today in 40 countries, including Canada, at the European Society of Cardiology (ESC) Congress.

31 Aug 2009

New Hospital Operating System solution from StatCom launched

StatCom, a developer of innovative healthcare software, announced today availability of its Hospital Operating System™ solution, a comprehensive patient throughput solution.

31 Aug 2009

SDBJ names A-Life Medical executive as the CFO of the Year

A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding products and services to the healthcare industry, announced today that Jaye Connolly, who serves as chief financial officer and chief operating officer, has been named CFO of the Year in the private company category of the 2009 San Diego Business Journal (SDBJ) CFO of the Year awards program.

31 Aug 2009

Intertek expands its REACH services portfolio

Intertek, (www.intertek.com), the leading provider of quality and safety services to a wide range of industries, has expanded its REACH services portfolio by providing comprehensive solutions to assist companies in complying with CLP, REACH, and GHS regulation requirements.

31 Aug 2009

MabCure featured in the August edition of Biotechnology Focus magazine

MabCure, Inc. (“MabCure”), a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies (MAbs) for the early detection of cancer, has been featured in the August edition of Biotechnology Focus, Canada's oldest and most successful magazine serving the Canadian life science industry.

31 Aug 2009

Navicure to provide clearinghouse services for three more clients

Navicure, a leading Internet-based medical claims clearinghouse for physician practices, today announced the addition of three South Carolina-based practices to its client roster. Lexington Heart Clinic, Premier Surgical Services, PA, and Sunshine Pediatrics all selected Navicure’s award-winning account receivables management solutions to help streamline and better manage the claims submission process.

31 Aug 2009

Illumina delivers its first individual genome sequence to Dr. Hermann Hauser

Illumina, Inc. today announced that it has delivered Hermann Hauser’s genome sequence. Dr. Hauser, Partner, Amadeus Capital Partners Ltd, is the first consumer to purchase Illumina’s individual genome sequencing service working with his physician, Michael Nova, MD, of Pathway Genomics.

From Illumina, Inc. 31 Aug 2009

XerGame products to be showcased at the US Open Tennis Championships

XerTech Inc., a leading manufacturer, seller, and distributer of cutting-edge, interactive fitness systems, today announced that it will showcase its XerGame products at the US Open Tennis Championships, starting today, August 31, and running through the end of the event on September 13, 2009.

31 Aug 2009

Health care reform will kill competition in most states: BestHealthcareRates.com

Management at BestHealthcareRates.com is astonished with the government’s claims that the health care reform that they are working hard to bring about will actually encourage competition. It is much more likely that it will kill competition in most states as the giant arrives in town and takes a portion of everybody’s business.

31 Aug 2009

Fifth annual Pathology Visions conference to showcase digital pathology technology and its healthcare applications

The newly formed Digital Pathology Association (DPA), a non-profit organization committed to the advancement of digital pathology applications in healthcare, invites interested pathology professionals to join them for the fifth annual Pathology Visions conference, to be held September 13-15 in San Diego, CA, at the Marriott Hotel and Marina.

31 Aug 2009

Walgreens to provide flue shots faster and easier this season

Walgreens (NYSE:WAG)(NASDAQ:WAG) is making it faster and easier to get a flu shot this season. The nation’s largest drugstore chain today announced it will begin offering seasonal flu shots on Sept. 1 at more than 7,000 points of care nationwide, including nearly all of its stores in 50 states and almost 350 in-store Take Care Clinics.

31 Aug 2009

Ardent Health Services selects Bravo Wellness for providing health assessment and wellness incentive services

Ardent Health Services has selected Bravo Wellness to provide health assessment and wellness incentive services to its 6,500 employees. In addition to improving employee health and productivity, the partnership has the potential to reduce the company’s overall health care costs, including out-of-pocket expenses for employees.

31 Aug 2009

Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the “Best New Product” at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.

31 Aug 2009

Fernando Pisani and 24 hockey players helped raise funds and awareness about Crohn's disease and ulcerative colitis

The spirit of giving back was as strong as ever this weekend at the first ever Score for Colitis & Crohn's event, which raised $20,000 for four gastrointestinal and digestive disease patient organizations from across the country. The Score for Colitis & Crohn's initiative, which took place at the West Edmonton Mall's Ice Palace on Saturday, August 29th, featured Fernando Pisani of the Edmonton Oilers and 24 aspiring young hockey enthusiasts who were all on hand to help raise funds and awareness about Crohn's disease and ulcerative colitis, the latter of which Pisani was diagnosed with in 2007.

31 Aug 2009

Merck undergoes restructuring after Schering-Plough merger

Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. (NYSE: MRK) today announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. Mr. Clark was named CEO of the combined company when the merger agreement was signed in March.

31 Aug 2009

Two senior members of Chertoff Group to provide operational advisory services to BioNeutral Group

BioNeutral Group, Inc. has expanded its relationship with the Chertoff Group (Washington, DC). Beginning September 1, 2009, two senior members of the Chertoff Group will provide dedicated strategic and operational advisory services to BioNeutral to enhance the company’s strategic alliances, corporate operations, product testing, regulatory approvals, capital strategies and sales to the public and private sectors.

31 Aug 2009

Health Net urges Americans to have their blood cholesterol measured

Tomorrow, September 1, marks the start of National Cholesterol Education Month. In support of this educational effort, Health Net, Inc., (NYSE: HNT) is encouraging those who haven't yet done so, to have their blood cholesterol measured and, if it's high, to embark on a cholesterol-lowering program.

31 Aug 2009

Four additional patents filed by Lifeline Biotechnologies for its First Warning System methods and technology

Lifeline Biotechnologies, Inc. (Pink Sheets:LLBO) today announced that it has filed four additional patents on its First Warning System™ methods and technology.

31 Aug 2009

Clinical trial results of Dabigatran proves its effectiveness for treating atrial fibrillation

Researchers today published promising results for a drug that could lead to a replacement for the very effective but difficult-to-use blood thinner Coumadin (sold generically as Warfarin), currently taken by millions of Americans to reduce their risk of stroke.

31 Aug 2009

Celladon announces completion of patient enrollment for Phase 2 CUPID clinical trial

Celladon Corporation and Momentum Research, Inc. today announced completion of enrollment of the phase 2 double-blind portion of the Calcium Up-regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) trial. Momentum Research is Celladon’s consulting and management organization with clinical expertise in the development of cardiovascular products and trials.

31 Aug 2009

Medical News

CLARIFY registry designed to increase knowledge and understanding of CAD was launched in 40 countries

New Hospital Operating System solution from StatCom launched

SDBJ names A-Life Medical executive as the CFO of the Year

Intertek expands its REACH services portfolio

MabCure featured in the August edition of Biotechnology Focus magazine

Navicure to provide clearinghouse services for three more clients

Illumina delivers its first individual genome sequence to Dr. Hermann Hauser

XerGame products to be showcased at the US Open Tennis Championships

Health care reform will kill competition in most states: BestHealthcareRates.com

Fifth annual Pathology Visions conference to showcase digital pathology technology and its healthcare applications

Walgreens to provide flue shots faster and easier this season

Ardent Health Services selects Bravo Wellness for providing health assessment and wellness incentive services

Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference

Fernando Pisani and 24 hockey players helped raise funds and awareness about Crohn's disease and ulcerative colitis

Merck undergoes restructuring after Schering-Plough merger

Two senior members of Chertoff Group to provide operational advisory services to BioNeutral Group

Health Net urges Americans to have their blood cholesterol measured

Four additional patents filed by Lifeline Biotechnologies for its First Warning System methods and technology

Clinical trial results of Dabigatran proves its effectiveness for treating atrial fibrillation

Celladon announces completion of patient enrollment for Phase 2 CUPID clinical trial

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News